For endocrine resistant breast cancer, compared with HMGB1 negative patients, HMGB1 positive patients who received CDK4 6 inhibitors treatment benefited more in PFS tamoxifen price Taken together, these results suggest that tamoxifen is a weak phenobarbital like inducer